Open AccessAssociation of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer
Author(s) -
Michael B. Foote,
James R. White,
Justin Jee,
Guillem Argilés,
Jonathan C. M. Wan,
Benoı̂t Rousseau,
Melissa S. Pessin,
Luis A. Díaz
Publication year - 2021
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2021.3585
Subject(s) - medicine , cancer , cohort , retrospective cohort study , odds ratio , oncology
Novel therapies for SARS-CoV-2 infection are urgently needed. Antineoplastic compounds that target cellular machinery used by SARS-CoV-2 for entry and replication, including angiotensin-converting enzyme 2 (ACE2), may disrupt SARS-CoV-2 activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom